Is it known whether burosumab passes into human breast milk?

It is unknown whether burosumab or its metabolites pass into human breast milk, and risk to newborns or infants cannot be excluded, so a decision about stopping breastfeeding or burosumab must weigh breastfeeding benefits for the child against treatment benefits for the woman.